drugset / Trial / NCT06809400
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to generate evidence of the safety, tolerability, and pharmacokinetics/pharmacodynamics of IV LY4006896 compared with placebo in healthy participants and participants with Parkinson's disease.
Timeline
- Start
- 2025-02-18
- Primary completion
- 2028-01
- Completion
- 2028-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY4006896 | Unknown | — | Intravenous |